Utilizing a state-of-the-art FACS platform, we offer high-fidelity isolation of CSCs based on functional markers like ALDH activity or surface markers, including CD133, CD44, and EpCAM for precision.
Cancer Stem Cell Antigen loaded DC Vaccine Development Service
Creative Biolabs provides a comprehensive solution for researchers looking to overcome the primary cause of cancer relapse: the cancer stem cell (CSC). We deliver high-purity, mature dendritic cells (DCs) primed with a tailored repertoire of CSC-specific antigens. By targeting the self-renewing engine of the tumor, our service assists in transforming "cold" tumors into "hot" ones, specifically eliminating the cells responsible for metastasis and drug resistance. Our approach bypasses traditional whole-tumor vaccine limitations by enriching for highly tumorigenic ALDH-high and CD133+ subpopulations, focusing the immune response on "master" cells to provide a higher ceiling for clinical efficacy and long-term remission.
Background What We Can Offer Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
Introduction of CSC Antigen-Loaded DC Vaccine
CSCs represent a minority of tumor cells with infinite self-renewal potential and intrinsic resistance to apoptosis. Conventional therapies often fail because they target rapidly dividing bulk tumor cells while sparing quiescent CSCs, leading to inevitable relapse. DC vaccines loaded with CSC-specific antigens, such as ALDH, CD44, and stemness-related exosomal cargo, effectively bridge this gap. Extensive research confirms that these vaccines prime the immune system to recognize the "stemness" signature, dismantling the immunological niche of the tumor. In conclusion, CSC-targeted DC vaccination is the definitive strategy for achieving long-term tumor control and preventing metastatic progression.
Versatile Platforms
To maximize the therapeutic potential of your pipeline, Creative Biolabs offers a modular suite of technologies designed to optimize every facet of DC-based CSC targeting. We provide end-to-end support from biomarker discovery to functional validation.
Precision CSC Biomarker Enrichment
Diverse Antigen Loading Modalities
Depending on research goals, we offer multiple loading strategies, including mRNA transfection for full-length expression, CSC-exosome pulsing for enhanced cross-presentation, and purified CSC-lysates for broad epitope library provision.
Optimized Maturation Cocktails
We offer specialized "Signal 3" induction protocols using various TLR agonists to ensure robust IL-12 production while effectively avoiding the induction of regulatory T-cells during the maturation process.
High-Resolution Potency Assays
Comprehensive validation services, including flow-based cytotoxicity assays and detailed cytokine profiling, are utilized to confirm the functional activation.
Explore Our Full Range of Capabilities - Inquire About Our Technology
Workflow
Creative Biolabs has established a streamlined, high-efficiency pipeline designed to transition your project from raw biological samples to a high-potency, ready-to-use dendritic cell vaccine.
Publication
This perspective reviews strategies to advance DC-based cancer vaccines. It highlights the central role of conventional type 1 DCs (cDC1s) in anti-tumor immunity and analyzes current limitations in vaccine efficacy. The article outlines innovative methods for ex vivo cDC1 generation and proposes a blueprint for engineering DCs through genetic and functional optimizations to enhance antigen presentation, migration, and modulation of the tumor microenvironment for personalized immunotherapy.
Fig.1 Enhancing dendritic cell vaccines through genetic strategies. 1
Why Choose Us?
Creative Biolabs stands at the intersection of stem cell biology and immunology. Our unique advantage lies in our ability to isolate rare CSC subpopulations with high fidelity, ensuring the resulting vaccine is a precision tool against the "seeds" of cancer. Supported by published data, our protocols consistently demonstrate superior induction of T-cell infiltration compared to traditional tumor-lysate methods. We specialize in subverting the CSC's natural immune evasion mechanisms, such as TGF-β secretion and low MHC-I expression, by providing the necessary costimulatory signals during the DC maturation phase.
Experience the Creative Biolabs Advantage - Get a Quote Today
FAQs
What makes CSC-loaded DCs better than standard tumor-lysate DCs?
CSC-loaded DCs specifically target the "roots" of the cancer responsible for relapse, whereas standard lysates are often dominated by bulk tumor antigens that do not address the quiescent stem cell population.
Can you work with very small tissue samples?
Yes, Creative Biolabs utilizes high-sensitivity sorting and mRNA amplification techniques to generate effective vaccines even from limited biopsy or fine-needle aspirate material, ensuring maximum utility of every sample.
Is this service available for rare cancer types?
Yes, our CSC identification platform is highly adaptable and can be tailored to the unique biomarker profiles of a wide range of solid tumors, including various rare indications.
Customer Review
-
Enhanced T-cell Specificity
Using Creative Biolabs' CSC-loaded DCs in our research has significantly facilitated our understanding of how ALDH+ cells evade the immune system. The high purity of sorted cells was impressive. - Dr. An S*** -
Seamless Exosome Integration
The use of CSC-derived exosomes as a cargo for DC loading provided a much broader antigenic breadth than our previous trials. Creative Biolabs handled the complex purification flawlessly. - Dr. Jm R***
Related Services
Dendritic Cell Engineering Service
Creative Biolabs provides DC engineering services, including isolation, genetic modification, and maturation. We optimize dendritic cells to enhance antigen presentation and stimulate potent, personalized immune responses.
Learn More →Antibody Maturation Service
Creative Biolabs provides antibody affinity maturation services, combining molecular evolution and phage display to enhance binding potency and reduce production costs.
Learn More →How to Contact Creative Biolabs
Creative Biolabs offers a world-class platform for the development of CSC antigen-loaded DC vaccines, combining advanced sorting, innovative loading, and potent maturation to target the source of malignancy.
Contact our scientists today to discuss your project and accelerate your path to a breakthrough immunotherapy.
Reference
- Perez, Caleb R., and Michele De Palma. "Engineering dendritic cell vaccines to improve cancer immunotherapy." Nature communications 10.1 (2019): 5408. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41467-019-13368-y
Download our brochureLoading case studies...
Online Inquiry